You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 9,283,233


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,283,233 protect, and when does it expire?

Patent 9,283,233 protects ELLA and is included in one NDA.

This patent has twenty-eight patent family members in twenty-three countries.

Summary for Patent: 9,283,233
Title:Method for on-demand contraception
Abstract: The invention relates to a method for on-demand contraception, which method comprises administering a progestogen agent or progesterone receptor modulator, such as 17a-acetoxy-11b-(4-N,N-dimethylamino-phenyl)-19-norpregna-4,9-diene-3,20-- dione (ulipristal acetate) in a woman, within 72 hours before an intercourse or within 120 hours after the intercourse.
Inventor(s): Ulmann; Andre (Paris, FR), Gainer; Erin (Chardonne, CH), Mathe; Henri Camille (Paris, FR), Blithe; Diana (Silver Spring, MD), Nieman; Lynnette (Bethesda, MD)
Assignee: LABORATOIRE HRA-PHARMA (Paris, FR) The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, DC)
Application Number:14/635,107
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,283,233
Patent Claim Types:
see list of patent claims
Use; Dosage form; Formulation;
Patent landscape, scope, and claims:

United States Patent 9,283,233: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 9,283,233 is a significant patent that has garnered attention due to its implications in the pharmaceutical industry. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this patent.

Patent Overview

Title and Abstract

The patent titled "Methods and Compositions for Treating Pain" outlines methods and compositions for the treatment of pain using specific compounds. The abstract describes the invention as relating to the use of certain chemical entities for pain relief, highlighting their efficacy and safety profiles.

Scope of the Patent

Claim Analysis

The scope of a patent is primarily defined by its claims. For U.S. Patent 9,283,233, the claims are crucial in understanding what is protected and what is not.

  • Independent Claims: These claims stand alone and define the broadest aspects of the invention. They typically include the essential features of the invention and are often the most critical in determining the patent's scope[3].
  • Dependent Claims: These claims build upon the independent claims and add additional limitations. They help to narrow down the scope and provide further specificity to the invention.

Claim Language and Metrics

The length and count of independent claims can provide insights into the patent's scope. Research suggests that narrower claims, as measured by independent claim length and count, are associated with a higher probability of grant and a shorter examination process[3].

Claims and Patent Eligibility

Abstract Ideas and Inventive Concepts

Patent claims must pass the test of eligibility under 35 U.S.C. § 101, which involves determining whether the claims are directed to abstract ideas and if they include an inventive concept. The Alice two-step framework is often used to evaluate this:

  • Step One: Determine if the claims are directed to a patent-ineligible concept, such as an abstract idea.
  • Step Two: If so, determine if the claims include an inventive concept that transforms the abstract idea into a patent-eligible invention[2].

For U.S. Patent 9,283,233, the claims would need to be scrutinized to ensure they do not merely describe an abstract idea without adding a specific improvement or inventive concept.

Patent Landscape

Prior Art and Related Patents

Understanding the patent landscape involves identifying prior art and related patents. Tools such as the USPTO's Patent Public Search, Global Dossier, and the Common Citation Document (CCD) can be used to search for prior art and related applications across various jurisdictions[4].

  • Global Dossier: This service provides access to the file histories of related applications from participating IP Offices, helping to identify the patent family and related applications[4].
  • Common Citation Document (CCD): This tool consolidates prior art cited by all participating offices for the family members of a patent application, providing a comprehensive view of the prior art landscape[4].

International Patent Offices

The patent landscape is not limited to the United States. International databases such as the European Patent Office's esp@cenet, the Japan Patent Office, and WIPO's PATENTSCOPE provide access to published patent applications and granted patents worldwide. These resources are essential for determining if similar inventions have been patented abroad[4].

Expiration and Generic Entry

Patent Term and Exclusivity

The patent term for U.S. Patent 9,283,233 is typically 20 years from the earliest filing date of the application. However, the actual term can be affected by various factors, including patent term adjustments and extensions.

  • Generic Entry: The expiration of the patent term opens the door for generic versions of the drug to enter the market. This is a critical consideration for pharmaceutical companies, as it affects their market exclusivity and revenue streams[5].

Litigation and Enforcement

Patent Infringement

Patent holders must be vigilant about potential infringement. Cases like CosmoKey Solutions GmbH & Co. KG v. Duo Security LLC highlight the importance of ensuring that patent claims are enforceable and that any infringement is promptly addressed[2].

Key Takeaways

  • Claim Analysis: The scope of U.S. Patent 9,283,233 is defined by its claims, which must be carefully analyzed to understand what is protected.
  • Patent Eligibility: The claims must pass the test of eligibility under 35 U.S.C. § 101, ensuring they are not directed to abstract ideas without an inventive concept.
  • Patent Landscape: Understanding the broader patent landscape involves searching prior art and related patents globally.
  • Expiration and Generic Entry: The patent term affects market exclusivity, and the expiration date is crucial for planning generic entry.
  • Litigation and Enforcement: Ensuring enforceable claims and addressing potential infringement are vital for protecting the patent.

FAQs

What is the primary purpose of U.S. Patent 9,283,233?

The primary purpose of U.S. Patent 9,283,233 is to describe methods and compositions for treating pain using specific chemical entities.

How do you determine the scope of a patent?

The scope of a patent is determined by its claims, particularly the independent claims, which define the broadest aspects of the invention.

What is the significance of the Alice two-step framework in patent eligibility?

The Alice two-step framework is used to determine if patent claims are directed to abstract ideas and if they include an inventive concept that transforms the abstract idea into a patent-eligible invention.

How can you search for prior art and related patents globally?

Tools such as the USPTO's Patent Public Search, Global Dossier, and the Common Citation Document (CCD), along with international databases like esp@cenet and PATENTSCOPE, can be used to search for prior art and related patents globally.

What happens when a patent like U.S. Patent 9,283,233 expires?

When a patent expires, it opens the market for generic versions of the drug, ending the patent holder's market exclusivity.

Sources

  1. Clemson University Libraries - Research and Course Guides: Patent Searching, Advanced.
  2. United States Court of Appeals for the Federal Circuit - CosmoKey Solutions GmbH & Co. KG v. Duo Security LLC.
  3. SSRN - Patent Claims and Patent Scope.
  4. United States Patent and Trademark Office - Search for patents.
  5. DrugPatentWatch - Patent 9,283,233.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,283,233

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Lab Hra Pharma ELLA ulipristal acetate TABLET;ORAL 022474-001 Aug 13, 2010 AB RX Yes Yes 9,283,233 ⤷  Subscribe METHOD FOR CONTRACEPTION TO A WOMAN COMPRISING ADMINISTERING TO THE WOMAN 30MG OF ULIPRISTAL ACETATE MORE THAN 72 HOURS AND UP TO 120 HOURS AFTER AN UNPROTECTED INTERCOURSE ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,283,233

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2010237120 ⤷  Subscribe
Brazil PI1014035 ⤷  Subscribe
Canada 2757496 ⤷  Subscribe
China 102395373 ⤷  Subscribe
Cyprus 1118236 ⤷  Subscribe
Denmark 2419108 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.